High- vs moderate-activity radioactive iodine does not improve recurrence-free survival in intermediate-risk papillary thyroid cancer.

Continuing semaglutide after initiating dialysis is safe and associated with lower rates of serious adverse events and ...

Social media posts about glucagon-like peptide-1 receptor agonists may identify patient concerns not captured in clinical trials.

The FDA has told Eli Lilly to study possible heart, liver and other risks tied to its new obesity drug Foundayo.

Cannabis use may impact glycemic control by impairing self-management behaviors and delaying gastric emptying among patients ...

Incidence patterns of STEMI and NSTEMI in type 1 diabetes depend on age, vascular history, and kidney function, a Finnish ...

Orforglipron was noninferior to insulin glargine regarding the time to first MACE-4 event in adults with type 2 diabetes and obesity or overweight.

Updated rules posted in a new charter outline operation of the ACIP panel, which guides vaccine use in the US and advises the CDC.

The FDA is encouraging TRT manufacturers to seek a new indication for low libido in men with idiopathic hypogonadism.

Alkylating and platinating agent exposure in childhood cancer survivors is associated with impaired spermatogenesis and azoospermia.

A report found that enforcement actions on illegal e-cigarettes by the DOJ have been relatively lackluster, given how large the issue is.

A judge turned down Louisiana officials’ request to stop mail order delivery of mifepristone nationwide while the case is still in court.